Register
Combination of axitinib and pembrolizumab safe and effective in patients with advanced renal cell cancer |
Journal Updates
eMediNexus Coverage from: 
Combination of axitinib and pembrolizumab safe and effective in patients with advanced renal cell cancer
eMediNexus,  12 February 2018
remove_red_eye 543 Views
#Internal Medicine #Nephrology #Oncology #Pathology and Lab Medicine

0 Read Comments                

Findings of a study presented February 10, 2018 at the ASCO Genitourinary Cancers Symposium in San Francisco demonstrate the safety and efficacy of axitinib in combination with pembrolizumab in treatment-naive patients with advanced renal cell cancer (aRCC).

To continue reading this article
Or

Continue reading your article with a Emedinexus account..
Free Membership!